CompletedNCT05384002

An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum

Studying Familial prostate cancer

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fondazione del Piemonte per l'Oncologia
Principal Investigator
Manolis Tsiknakis
FORTH
Intervention
Magnetic Resonance Imaging(diagnostic_test)
Enrollment
14000 target
Eligibility
18-85 years · MALE
Timeline
2021 – 2025

Study locations (1)

Collaborators

Fundacao Champalimaud · Stichting Katholieke Universiteit · Fundacion Para La Investigacion Hospital La Fe · University of Pisa · Institut Paoli-Calmettes · Hacettepe University · Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta · JCC DIAGNOSTIC IMAGING · National Cancer Institute (NCI) · Agios Savas · Royal Marsden NHS Foundation Trust · QS INSTITUTO DE INVESTIGACION E INNOVACION SL · IDRYMA TECHNOLOGIAS KAI EREVNAS · Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy · THE GENERAL HOSPITAL CORPORATION · BIOTRONICS 3D LIMITED · Advantis Medical Imaging · QUIBIM SOCIEDAD LIMITADA · University of Vienna

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05384002 on ClinicalTrials.gov

Other trials for Familial prostate cancer

Additional recruiting or active studies for the same condition.

See all trials for Familial prostate cancer →

← Back to all trials